Sulfasalazine: My study [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-05-28 12:04 (439 d 06:43 ago) – Posting: # 20304
Views: 1,644

Hi Irene,

» Have anyone here ever conducted Bioequivalence study of Sulfasalazine?

Yes. My results (T1: 1×4 500 mg IR, T2: 1×4 500 mg enteric coated, R: 2,000 mg suspension, six-sequence Williams’ design, sampling for 60 hours, washout two weeks, 24 eligible subjects, plasma and urine). This study was performed for the originator. Both test products showed lower bioavailabilities of sulfasalazine and 5-ASA, whereas sulfapyridine and N-acetylsulfapyridine were BE. CVs for plasma:Given the high variabilities of Sulfasalazine and 5-ASA I suggest reference-scaling.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,987 posts in 4,375 threads, 1,460 registered users;
online 62 (0 registered, 62 guests [including 15 identified bots]).
Forum time: Sunday 18:47 CEST (Europe/Vienna)

The interpretation of facts in a certain way
stimulates other scientists’ thoughts.    Róbert Bárány

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5